Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group
暂无分享,去创建一个
A. Iagnocco | C. Campochiaro | G. de Luca | L. Dagna | C. Selmi | R. Giacomelli | F. Iannone | R. Foti | R. De Angelis | F. Francioso | P. Ruscitti | G. Murdaca | G. Cuomo | C. Ferri | C. Naclerio | L. Massaro | F. Caso | I. Cavazzana | M. De Santis | M. Visentini | E. Pigatto | I. Di Cola | J. Ciaffi | M. Reta | L. Mancarella | V. Brusi | F. Motta | V. Raimondo | G. Varcasia | R. Pellegrini | D. Olivo | O. Addimanda | A. Lo Gullo | R. Foti | S. Lorusso | Francesco Ursini | V. Caira | Elena Marchetti | J. Luppino
[1] S. Manrique-Arija,et al. Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study , 2023, RMD Open.
[2] K. Loré,et al. Innate immune mechanisms of mRNA vaccines , 2022, Immunity.
[3] K. Migita,et al. New-onset dermatomyositis following COVID-19: A case report , 2022, Frontiers in Immunology.
[4] A. Mir,et al. New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literature , 2022, JAAD Case Reports.
[5] A. Gorji,et al. Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review , 2022, Immunologic Research.
[6] Chun-Bing Chen,et al. New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review , 2022, American Journal of Clinical Dermatology.
[7] A. Al-Allaf,et al. A Case Series and Literature Review of the Association of COVID-19 Vaccination With Autoimmune Diseases: Causality or Chance? , 2022, Cureus.
[8] Chung-Jen Chen,et al. New‐onset inflammatory arthritis after COVID‐19 vaccination: A systematic review , 2022, International journal of rheumatic diseases.
[9] O. Watson,et al. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study , 2022, The Lancet Infectious Diseases.
[10] Junfen Fan,et al. COVID-19 vaccine development: milestones, lessons and prospects , 2022, Signal Transduction and Targeted Therapy.
[11] J. Sparks,et al. DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study , 2022, Seminars in Arthritis and Rheumatism.
[12] D. Fine,et al. New-onset lupus nephritis associated with COVID-19 infection , 2022, Lupus.
[13] B. Tai,et al. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis , 2022, The Lancet Respiratory Medicine.
[14] B. Haagmans,et al. SARS-CoV-2 pathogenesis , 2022, Nature Reviews Microbiology.
[15] M. Cutolo,et al. Detailed videocapillaroscopic microvascular changes detectable in adult COVID-19 survivors , 2022, Microvascular Research.
[16] A. Abdelmaksoud,et al. SARS‐CoV‐2 vaccination‐induced cutaneous vasculitis: Report of two new cases and literature review , 2022, Dermatologic therapy.
[17] Quanzhen Li,et al. Autoimmunity is a hallmark of post-COVID syndrome , 2022, Journal of translational medicine.
[18] A. Negida,et al. A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines , 2022, Journal of Thrombosis and Thrombolysis.
[19] S. Metyas,et al. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series. , 2022, Current rheumatology reviews.
[20] A. Iagnocco,et al. Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases , 2022, Clinical Rheumatology.
[21] P. Maes,et al. Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern , 2021, bioRxiv.
[22] D. Ye,et al. New‐onset autoimmune phenomena post‐COVID‐19 vaccination , 2021, Immunology.
[23] P. Merkel,et al. Medication Interruptions and Subsequent Disease Flares During the COVID‐19 Pandemic: A Longitudinal Online Study of Patients With Rheumatic Disease , 2021, Arthritis care & research.
[24] S. Heymans,et al. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms , 2021, Nature Reviews Cardiology.
[25] Stanley Xu,et al. Guillain-Barre Syndrome after COVID-19 Vaccination in the Vaccine Safety Datalink , 2021, medRxiv.
[26] X. Mariette,et al. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry , 2021, Annals of the Rheumatic Diseases.
[27] G. Hernández-Molina,et al. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis , 2021, Cells.
[28] P. Dieudé,et al. Polymyalgia rheumatica following COVID-19 vaccination: A case-series of ten patients , 2021, Joint Bone Spine.
[29] A. Iagnocco,et al. Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases , 2021, Annals of the Rheumatic Diseases.
[30] F. Cacciapaglia,et al. Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups , 2021, Journal of Autoimmunity.
[31] J. Kelton,et al. Lessons from vaccine-induced immune thrombotic thrombocytopenia , 2021, Nature Reviews Immunology.
[32] B. Terrier,et al. Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study. , 2021, Rheumatology.
[33] L. Arendt-Nielsen,et al. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived to SARS-CoV-2 infection: a systematic review and meta-analysis. , 2021, Pain.
[34] A. Iagnocco,et al. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey , 2021, RMD Open.
[35] S. Kent,et al. Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection , 2021, medRxiv.
[36] A. Iagnocco,et al. Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group , 2021, Annals of the Rheumatic Diseases.
[37] D. Brodie,et al. Post-acute COVID-19 syndrome , 2021, Nature Medicine.
[38] H. Bézanahary,et al. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review. , 2020, Autoimmunity reviews.
[39] G. Ramírez-Olivencia,et al. Incidence, Characteristics, Laboratory Findings and Outcomes in Acro-Ischemia in COVID-19 Patients , 2020, Vascular health and risk management.
[40] C. Delaugerre,et al. COVID‐19–Related IgA Vasculitis , 2020, Arthritis & rheumatology.
[41] Jean Kanitakis,et al. Chilblain-like acral lesions during the COVID-19 pandemic (“COVID toes”): Histologic, immunofluorescence, and immunohistochemical study of 17 cases , 2020, Journal of the American Academy of Dermatology.
[42] B. Frediani,et al. Polymyalgia rheumatica following infective triggers or vaccinations: a different subset of disease? , 2020, Reumatologia.
[43] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[44] Gheyath K Nasrallah,et al. Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms , 2019, Viruses.
[45] Y. Shoenfeld,et al. The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry , 2018, Clinical Rheumatology.
[46] E. Decullier,et al. A bicentre retrospective study of features and outcomes of patients with reactive arthritis. , 2017, Joint, bone, spine : revue du rhumatisme.
[47] J. Marks,et al. Viral arthritis. , 2016, Clinical medicine.
[48] E. Toussirot,et al. Vaccination and Induction of Autoimmune Diseases. , 2015, Inflammation & allergy drug targets.
[49] Yin Zheng,et al. Administer and collect medical questionnaires with Google documents: a simple, safe, and free system. , 2013, Applied medical informatics.
[50] Y. Shoenfeld,et al. Vaccines and Autoimmunity , 2013, International journal of immunopathology and pharmacology.
[51] D. Vassilopoulos,et al. Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations , 2008, Arthritis research & therapy.
[52] B. Leeb,et al. A disease activity score for polymyalgia rheumatica , 2004, Annals of the rheumatic diseases.
[53] Christiane,et al. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.
[54] J. Bach,et al. Infections and autoimmune diseases. , 2005, Journal of autoimmunity.
[55] Christiane,et al. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.
[56] M. Prevoo,et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.